Altered expression of CKs 14/20 is an early event in a rat model of multistep bladder carcinogenesis-Reference-Cited by-同舟云学术

Altered expression of CKs 14/20 is an early event in a rat model of multistep bladder carcinogenesis

Published:2015-10 Issue:5 Volume:96 Page:319-325
ISSN:0959-9673
Container-title:International Journal of Experimental Pathology
language:en
Short-container-title:Int. J. Exp. Pathol.

Author:

Gil da Costa Rui M.¹²,Oliveira Paula A.³⁴,Vasconcelos-Nóbrega Carmen⁵⁶,Arantes-Rodrigues Regina⁴,Pinto-Leite Rosário⁷,Colaço Aura A.³⁸,de la Cruz Luis F.⁹,Lopes Carlos²

Affiliation:

1. LEPABE; Departamento de Engenharia Química; Faculdade de Engenharia da Universidade do Porto (FEUP); Porto Portugal

2. Grupo de Patologia e Terapêutica Experimental; CI-IPOP; Instituto Português de Oncologia; Porto Portugal

3. Departamento de Ciências Veterinárias; Universidade de Trás-os-Montes e Alto Douro (UTAD); Vila Real Portugal

4. CITAB; UTAD; Vila Real Portugal

5. Instituto Politécnico de Viseu; Escola Agrária de Viseu; Viseu Portugal

6. CECA; Universidade do Porto; Porto Portugal

7. Laboratorio de Citogenética; Departamento de Genética Humana; Centro Hospitalar de Trás-os-Montes e Alto Douro; Vila Real Portugal

8. ECAV; UTAD; Vila Real Portugal

9. Departamento de Fisiologia; Faculdade de Veterinária; Universidade de Santiago de Compostela; Lugo Spain

Funder

Fundação para a Ciência e a Tecnologia

Portuguese Government

European Social Fund

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Reference24 articles.

1. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference;Amin;Am. J. Surg. Pathol.,2014

2. Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary carcinoma;Arantes-Rodrigues;Tumour Biol.,2013

3. Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer;Choi;Nat. Rev. Urol.,2014

4. Utility of cytokeratin 5/6, cytokeratin 20 and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia;Edgecombe;Appl. Immunohistochem. Mol. Morphol.,2012

5. Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder;Gee;Urol. Oncol.,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression;International Journal of Molecular Sciences;2022-07-15

2. Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy;Veterinary Sciences;2022-02-28

3. CK14 Expression Identifies a Basal/Squamous-Like Type of Papillary Non-Muscle-Invasive Upper Tract Urothelial Carcinoma;Frontiers in Oncology;2020-04-24

4. Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5/6, 14 and 20;Annals of Diagnostic Pathology;2019-12

5. Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review;Pathology - Research and Practice;2019-06